Semaglutide to Tirzepatide Conversion Chart: Compare Doses

Why a Conversion Chart Matters When Switching GLP‑1 Medications

Benefits of a Conversion Chart

Switching between GLP‑1 medications creates real dosing uncertainty for many users. Jordan, a 42‑year‑old managing type‑2 diabetes, may worry about dose equivalence and gastrointestinal side effects. A clear conversion chart removes guesswork and gives a simple reference during transitions.

Structured conversion approaches can improve tolerability and speed up dose milestones. Some reviews suggest structured switching protocols may improve tolerability (Pharmaceutical Journal). According to a Doctronic AI blog post, clinics report faster time to target dose when using a structured guide (Doctronic AI).

How Pepio Supports Tracking

This guide shows how to compare semaglutide and tirzepatide equivalents, track changes over time, and log transitions for clearer notes.

Common conversion problems include:

• Confusing mg, mcg, and mL units when converting doses
• Differences in vial concentration between branded and compounded products
• Converting mcg to syringe units (U‑100 vs U‑40) and misreading syringe marks
• Applying the wrong titration or dose ladder when switching medications
• Rounding or math errors when calculating dose per vial or days of supply
• Mislabeling or inconsistent recording during a medication transition

Pepio helps you keep those records in one place so you can review dose history, symptoms, and next‑dose dates. Pepio’s 24 web tools are 100% free with no sign‑up — see the Tools hub. The Pepio iOS app stores your logs locally (privacy‑first), sends push reminders, and exports clean CSVs for clinician visits. Teams using Pepio report cleaner tracking and easier conversations with clinicians.

Always follow your clinician’s instructions when switching medications. Learn more about Pepio’s approach to tracking dose transitions and preparing for follow‑up visits.

Step‑by‑Step Conversion and Tracking Process

This section gives a clear, practical seven‑step workflow for converting a semaglutide weekly dose to a tirzepatide equivalent and tracking the transition. Follow each step to keep records accurate and to preserve a clean symptom and weight history while you consult your clinician.

1. Step 1: Gather Your Current Semaglutide Details — record your weekly dose, injection day, and any recent dose changes so you have an accurate baseline. Pitfall: Missing the exact weekly dose leads to an inaccurate conversion.

2. Step 2: Understand the Standard Conversion Factor — There is no official dose‑equivalence between semaglutide and tirzepatide. Always use the dose prescribed by your clinician and the medication label. Use Pepio’s semaglutide vs tirzepatide side‑by‑side reference and per‑drug unit calculators to document what your clinician prescribes—Pepio does not provide dosing recommendations. Pitfall: Assuming a 1:1 conversion or skipping clinician input.

3. Step 3: Use Pepio’s per‑medication calculators — enter your prescribed dose to convert into syringe units and confirm your vial concentration (mg/µg/mL). Consult Pepio’s semaglutide vs tirzepatide comparison chart for educational context. Pepio does not compute cross‑drug equivalent doses. Pitfall: Forgetting to confirm the correct unit (mg vs g) when you record numbers.

4. Step 4: Record the Equivalent Tirzepatide Dose in Pepio — add a new injection entry with the calculated dose, date, and injection site so your dose history stays intact. Pitfall: Overwriting an old entry instead of adding a new log and losing timeline context.

5. Step 5: Set a Dose Reminder in Pepio — schedule the next weekly injection to maintain cadence and avoid missed doses. Pitfall: Not updating reminders after a dose or schedule change.

6. Step 6: Log Symptoms and Weight After the First Tirzepatide Dose — capture nausea, appetite, food‑noise, and weight daily to spot early tolerability patterns; gradual titration reduces GI effects in many cases (Pharmaceutical Journal). Pitfall: Skipping daily symptom entries and losing useful trend data.

7. Step 7: Review and Adjust — after about two weeks, compare symptom trends and weight change, then discuss observations with your clinician; do not self‑adjust your dose. If you miss a dose, some guidance allows administration within 96 hours, but always confirm with your prescriber or medication label (NCBI StatPearls). Pitfall: Using your chart to change doses without professional input.

Pepio helps you keep conversions, reminders, and symptom logs in one organized place so you can present clear notes to your clinician during follow up. Learn more about Pepio’s approach to tracking medication transitions and try the conversion tools as an organizational aid.

Pepio is for organization and self‑tracking only. Pepio does not provide medical advice, diagnosis, treatment, dosing recommendations, or protocol recommendations. Always follow the instructions from your clinician, prescriber, pharmacist, medication label, or care team.

Troubleshooting Common Conversion Issues

Below are three common conversion problems and concise, non‑prescriptive fixes. Each includes a safety note so you know when to log and when to contact your clinician.

• Issue: Calculator shows a dose that doesn’t match your prescription – Solution: Verify unit selection (mg vs g) and double-check the conversion factor with your clinician.
• Issue: New symptoms appear more intensely – Solution: Record severity in Pepio, wait 48 hours, and consult your provider before assuming a dosing error.
• Issue: Reminder fires on the wrong day – Solution: Edit the reminder in Pepio and confirm the weekly interval. If the mismatch looks like a formatting or unit error, logging the exact values and the prescription note is usually enough. Tools and guides can reduce simple math mistakes and save clinician time during transitions (see Doctronic AI on workflow gains). If symptoms escalate quickly or you see alarming signs, contact your clinician immediately. Practical switching guides recommend clinician involvement for any dose or titration change (Pharmaceutical Journal).

Keep safety front and center. Do not self‑adjust doses based on conversion tools alone. Use clear logs and timestamps to share with your clinician. Learn more about how Pepio helps you document conversions and symptoms, and explore Pepio’s approach to keeping your dose history organized before clinician visits.

Quick Checklist & Next Steps

If you’re planning a switch from semaglutide to tirzepatide, use a short checklist to stay organized. Structured checklists and monitoring are commonly recommended in clinical guidance when transitioning therapies.

• ✅ Gather current semaglutide dose.
• ✅ Confirm the tirzepatide starting dose prescribed by your clinician, then log it in Pepio. Set Pepio’s weekly reminders and use symptom/weight logs to monitor tolerability.
• ✅ Use Pepio’s calculator and log the new tirzepatide dose.
• ✅ Set a weekly reminder and start symptom tracking.
• ✅ Review trends after two weeks and discuss any concerns with your clinician.

A commonly referenced conversion starting point is 1 mg semaglutide → 2 mg tirzepatide (Doctronic AI Blog). Track symptoms such as nausea, appetite, and blood glucose at least twice weekly for the first two weeks (Pharmaceutical Journal). Review tolerability at week two and share your notes with your clinician if needed. Pepio helps you keep dose history, reminders, and symptom logs in one place so you arrive to appointments prepared. Pepio is for organization and self-tracking only and does not provide medical advice. Always follow your clinician, prescriber, pharmacist, or medication label.